ASCO 2022 Conference Coverage
ASCO 2022 Efficacy & Safety of Dostarlimab in dMMR Solid Tumors: The Analysis of 2 Cohorts in the GARNET Study
By
ASCO 2022 Conference Coverage
FEATURING
Thierry André
By
ASCO 2022 Conference Coverage
FEATURING
Thierry André
Comments 0
Login to view comments.
Click here to Login
